Drugs / CSL Limited Influenza Virus Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00825162 | Mar 2009 → Feb 2010 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CSL Limited Influenza Virus Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00825162 ↗ |
| Modality | Vaccine | “a 2009 trivalent inactivated split-virion influenza vaccine” PMID 23551933 ↗ Apr 2013 |